SII and SIRI can be used as clinical indicators to predict the inflammatory activity and prognosis of patients with Behçet's disease with uveitis, and the predictive efficacy of SII is better than SIRI in predicting the onset and inflammatory activity of BU, which provides a basis for early clinical identification of high-risk BU patients and intervention decisions.